Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration

Heart rate variability (HRV) is reduced in diabetes mellitus (DM) patients, suggesting dysfunction of cardiac autonomic regulation and an increased risk for cardiac events. The aim of this paper was to examine the associations of blood glucose level (BGL), glycated hemoglobin (HbA1c) and duration of...

Full description

Bibliographic Details
Main Authors: Mika P. Tarvainen, Tomi Petteri Laitinen, Jukka Antero Lipponen, David eCornforth, Herbert eJelinek
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00130/full
_version_ 1818201982556438528
author Mika P. Tarvainen
Mika P. Tarvainen
Tomi Petteri Laitinen
Jukka Antero Lipponen
David eCornforth
Herbert eJelinek
author_facet Mika P. Tarvainen
Mika P. Tarvainen
Tomi Petteri Laitinen
Jukka Antero Lipponen
David eCornforth
Herbert eJelinek
author_sort Mika P. Tarvainen
collection DOAJ
description Heart rate variability (HRV) is reduced in diabetes mellitus (DM) patients, suggesting dysfunction of cardiac autonomic regulation and an increased risk for cardiac events. The aim of this paper was to examine the associations of blood glucose level (BGL), glycated hemoglobin (HbA1c) and duration of diabetes with cardiac autonomic regulation assessed by HRV analysis. Resting electrocardiogram (ECG), recorded over 20 minutes in supine position, and clinical measurements of 189 healthy controls and 93 type 2 DM (T2DM) patients were analyzed. HRV was assessed using several time-domain, frequency-domain and nonlinear methods. HRV parameters showed a clear difference between healthy controls and T2DM patients. Hyperglycemia was associated with increase in mean heart rate and decrease in HRV, indicated by negative correlations of BGL and HbA1c with mean RR interval and most of the HRV parameters. Duration of diabetes was strongly associated with decrease in HRV, the most significant decrease in HRV was found within the first 5-10 years of the disease. In conclusion, elevated blood glucose levels have an unfavorable effect on cardiac autonomic function and this effect is pronounced in long-term T2DM patients. The most significant decrease in HRV related to diabetes and thus presence of autonomic neuropathy was observed within the first 5-10 years of disease progression.
first_indexed 2024-12-12T03:02:12Z
format Article
id doaj.art-10e7f338c4a5436b8b1817e0611ac89e
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-12T03:02:12Z
publishDate 2014-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-10e7f338c4a5436b8b1817e0611ac89e2022-12-22T00:40:36ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922014-08-01510.3389/fendo.2014.00130105534Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease DurationMika P. Tarvainen0Mika P. Tarvainen1Tomi Petteri Laitinen2Jukka Antero Lipponen3David eCornforth4Herbert eJelinek5University of Eastern FinlandKuopio University HospitalUniversity of Eastern Finland and Kuopio University HospitalUniversity of Eastern FinlandUniversity of NewcastleCharles Sturt University, AlburyHeart rate variability (HRV) is reduced in diabetes mellitus (DM) patients, suggesting dysfunction of cardiac autonomic regulation and an increased risk for cardiac events. The aim of this paper was to examine the associations of blood glucose level (BGL), glycated hemoglobin (HbA1c) and duration of diabetes with cardiac autonomic regulation assessed by HRV analysis. Resting electrocardiogram (ECG), recorded over 20 minutes in supine position, and clinical measurements of 189 healthy controls and 93 type 2 DM (T2DM) patients were analyzed. HRV was assessed using several time-domain, frequency-domain and nonlinear methods. HRV parameters showed a clear difference between healthy controls and T2DM patients. Hyperglycemia was associated with increase in mean heart rate and decrease in HRV, indicated by negative correlations of BGL and HbA1c with mean RR interval and most of the HRV parameters. Duration of diabetes was strongly associated with decrease in HRV, the most significant decrease in HRV was found within the first 5-10 years of the disease. In conclusion, elevated blood glucose levels have an unfavorable effect on cardiac autonomic function and this effect is pronounced in long-term T2DM patients. The most significant decrease in HRV related to diabetes and thus presence of autonomic neuropathy was observed within the first 5-10 years of disease progression.http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00130/fullBlood GlucoseHyperglycemiaHeart rate variabilitydurationHbA1ccardiac autonomic neuropathy
spellingShingle Mika P. Tarvainen
Mika P. Tarvainen
Tomi Petteri Laitinen
Jukka Antero Lipponen
David eCornforth
Herbert eJelinek
Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
Frontiers in Endocrinology
Blood Glucose
Hyperglycemia
Heart rate variability
duration
HbA1c
cardiac autonomic neuropathy
title Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
title_full Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
title_fullStr Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
title_full_unstemmed Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
title_short Cardiac Autonomic Dysfunction in Type 2 Diabetes – Effect of Hyperglycemia and Disease Duration
title_sort cardiac autonomic dysfunction in type 2 diabetes effect of hyperglycemia and disease duration
topic Blood Glucose
Hyperglycemia
Heart rate variability
duration
HbA1c
cardiac autonomic neuropathy
url http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00130/full
work_keys_str_mv AT mikaptarvainen cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration
AT mikaptarvainen cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration
AT tomipetterilaitinen cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration
AT jukkaanterolipponen cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration
AT davidecornforth cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration
AT herbertejelinek cardiacautonomicdysfunctionintype2diabeteseffectofhyperglycemiaanddiseaseduration